RE:ADK ... Google ... Perception and Trust !Google violating privacy rules is nothing new.. But something investors might be curious to learn is that another competitor, IDx has partnered with IBM Watson, and is filing for FDA approval:
IDx, an early-stage medical device company focused on developing software-based algorithms that can identify disease in medical images is currently conducting an FDA clinical trial to obtain clearance for its first product, IDx-DR by the end of summer 2017. IDx-DR is a screening solution for diabetic retinopathy. IDx also has algorithms in development for the detection of macular degeneration, glaucoma, Alzheimer’s disease, cardiovascular disease, and stroke risk. https://hitconsultant.net/2017/07/06/new-ai-device-diabetes-eye-screening/
Today IBM (NYSE: IBM) Watson Health and IDx announced a five-year strategic alliance to advance global eye health through cognitive computing applications. This announcement comes shortly after IBM announced that IDx joined the IBM Watson Medical Imaging Collaborative, which includes 24 healthcare leaders worldwide.
The partnership leverages more than a decade of IDx's medical image analysis work and IBM's global reach, and aims to help patients with serious eye conditions. As part of the alliance, IBM Watson Health intends to distribute IDx's automated diabetic retinopathy (DR) screening solution, IDx-DR, in the 31 countries that comprise the European Economic Area. This distribution may be expanded to Australia, Canada, and the United States pending regulatory approval.
https://www.eyediagnosis.net/single-post/2017/03/08/IBM-WH-OEM